article thumbnail

Cybersecurity in pharma: Securing the future

Pharmaceutical Technology

Cybersecurity challenges As per a Healthcare Information and Management Systems Society (HIMSS) 2022 survey, there is a need for greater awareness on Health Insurance Portability and Accountability Act (HIPAA) and data privacy along with other measures. Pharmaceutical companies that are publicly traded will need to pay attention,” warns Kim.

HIPAA 110
article thumbnail

Three Ways Pharma Advertisers Can Benefit from Attention Metrics

Pharma Marketing Network

Reaching these audiences is further complicated by HIPAA and FTC regulations — not to mention international laws like GDPR and the gradual deprecation of third-party cookies, which all marketers must consider. For pharmaceutical companies, this need is even more pressing.

HIPAA 98
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Toni R. Hofhine, President of ATCOR Medical (CardieX) Shares Insights from Pulse- a New at-home Heart Health Monitor

PharmaShots

The app syncs to a HIPAA-compliant, cloud-based patient management portal to facilitate remote patient monitoring and enables physicians to incorporate the Pulse into their clinical workflow.

article thumbnail

Ep. 007 – Holly Henry and Kamran Shah Podcast Transcript

Pharma Marketing Network

Now most pharmaceutical companies that are global in nature will already encounter this from a European compliance standpoint with the GDPR regulation that is more geared toward the US European union. So, this isn’t really something that would technically be super new to pharmaceutical companies that are global.

HIPAA 40
article thumbnail

Healthcare data management: resolving consent, compliance, and privacy issues

Pharmaceutical Technology

Breaches of HIPAA in the US can result in fines of up to $50,000. One solution that increasing numbers of pharmaceutical companies, healthcare providers, and clinical research organisations are turning to is Cassie by Syrenis, which is a Consent Management Platform (CMP). Grouping and matching for medical data.

HIPAA 52